Please login to the form below

Not currently logged in
Email:
Password:

BenevolentAI appoints new head of cheminformatics

Dr Nathan Brown joins from the Institute of Cancer Research

Artificial Intelligence (AI) group BenevolentAI has appointed Dr Nathan Brown as its new head of cheminformatics.

Brown joins the group from the Institute of Cancer Research (ICR), where he founded and led the new In Silico Medicinal Chemistry Group, which focussed on medicinal chemistry research towards novel cancer treatments.

He also has experience as a software designer and has developed many novel algorithms to maximise the impact of the experimental data generated in medicinal chemistry and cancer biology.

Jackie Hunter, CEO of BenevolentBio, the bioscience subsidiary of BenevolentAI, said: “Nathan is a recognised leader in the field of cheminformatics, molecular informatics and computational chemistry.

“He has done exceptional work in the development of innovative anti-cancer therapies in an academic setting and his work is respected and well published. We are delighted to have him on board.”

Brown succeeds Mark Davies who has been promoted to vice president, Biomedical Informatics.

1st August 2017

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Top-10 Reasons Why You Should be Adding Asynchronous Virtual Touchpoints Between Your Real-time Meetings
...
Flu
Influenza – the risk to vulnerable populations
Why we can't get complacent about flu vaccination...
dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...